These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26598798)

  • 1. Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.
    Mao Y; Tao M; Jia X; Xu H; Chen K; Tang H; Li D
    Sci Rep; 2015 Nov; 5():17102. PubMed ID: 26598798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
    Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
    Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis.
    Wan G; Sun X; Li F; Wang X; Li C; Li H; Yu X; Cao F
    Cell Physiol Biochem; 2018; 49(3):837-847. PubMed ID: 30184547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.
    Jeon CY; Li D; Cleary S; Stolzenberg-Solomon R; Bosetti C; La Vecchia C; Porta M; Toriola AT; Hung RJ; Kurtz RC; Olson SH
    Pancreas; 2018 Mar; 47(3):314-320. PubMed ID: 29401167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of diabetes and perineural invasion in pancreatic cancer.
    Sahin IH; Shama MA; Tanaka M; Abbruzzese JL; Curley SA; Hassan M; Li D
    Cancer Med; 2012 Dec; 1(3):357-62. PubMed ID: 23342285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
    Ma J; Wang J; Ge L; Long B; Zhang J
    Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704.
    Bitterman DS; Winter KA; Hong TS; Fuchs CS; Regine WF; Abrams RA; Safran H; Hoffman JP; Benson AB; Kasunic T; Mulcahy M; Strauss JF; DiPetrillo T; Stella PJ; Chen Y; Plastaras JP; Crane CH
    Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):201-211. PubMed ID: 32858111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative dysglycemia is associated with decreased survival in patients with pancreatic neuroendocrine neoplasms.
    Sandini M; Strobel O; Hank T; Lewosinska M; Nießen A; Hackert T; Büchler MW; Schimmack S
    Surgery; 2020 Mar; 167(3):575-580. PubMed ID: 31889543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis.
    Takumoto Y; Sasahara Y; Narimatsu H; Akazawa M
    JAMA Netw Open; 2022 Jan; 5(1):e2145515. PubMed ID: 35099549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer.
    Kleeff J; Costello E; Jackson R; Halloran C; Greenhalf W; Ghaneh P; Lamb RF; Lerch MM; Mayerle J; Palmer D; Cox T; Rawcliffe CL; Strobel O; Büchler MW; Neoptolemos JP
    Br J Cancer; 2016 Sep; 115(7):887-94. PubMed ID: 27584663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.
    Jämsä P; Jämsen E; Huhtala H; Eskelinen A; Oksala N
    Clin Orthop Relat Res; 2018 Jun; 476(6):1284-1292. PubMed ID: 29601379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and pancreatic cancer survival: a prospective cohort-based study.
    Toriola AT; Stolzenberg-Solomon R; Dalidowitz L; Linehan D; Colditz G
    Br J Cancer; 2014 Jul; 111(1):181-5. PubMed ID: 24786605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
    Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
    Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Celiac Neurolysis and Splanchnicectomy on Survival in Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Ye L; Schorn S; Pergolini I; Safak O; Demir E; Istvanffy R; Friess H; Ceyhan GO; Demir IE
    Dig Surg; 2022; 39(1):51-59. PubMed ID: 34903684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette Smoking and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.
    Ben QW; Liu J; Sun YW; Wang LF; Zou DW; Yuan YZ
    Pancreas; 2019 Sep; 48(8):985-995. PubMed ID: 31425484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review.
    Khadka R; Tian W; Hao X; Koirala R
    Int J Surg; 2018 Apr; 52():342-346. PubMed ID: 29535016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.